PlusmanLLC

POLARIS

AI-Powered ICI Treatment Predictor for Personalized Oncology Care

POLARIS predicts individual patient response to ICI treatments using AI-powered analysis of CT scans and clinical data.

Key Benefits

Personalized Treatment Planning:

Helps oncologists choose the most effective immunotherapy.

Supports Evidence-Based Decision Making:

Quantifies survival and response likelihood for different ICIs.

Clinical Value & Use Cases

Use Cases: Predicting best-fit ICI therapy for NSCLC patients.

　・ Assisting oncologists in therapy selection to improve patient outcomes.

　・ Reducing trial-and-error in immune checkpoint inhibitor (ICI) selection.

Integration & Implementation

Deployment Options:

　・Seamless integration with hospital IT systems.

Request a demo or contact us for partnership and licensing opportunities.